losartan has been researched along with Cancer of Endometrium in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "And the MTT assay was performed in endometrial cancer cells following anti-miR-155 and AGTR1 blocker (losartan) treatment, alone and in combination." | 1.38 | Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells. ( Bae, DS; Choi, CH; Choi, JJ; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Park, YA; Song, SY; Song, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CH | 1 |
| Park, YA | 1 |
| Choi, JJ | 1 |
| Song, T | 1 |
| Song, SY | 1 |
| Lee, YY | 1 |
| Lee, JW | 1 |
| Kim, TJ | 1 |
| Kim, BG | 1 |
| Bae, DS | 1 |
1 other study available for losartan and Cancer of Endometrium
| Article | Year |
|---|---|
Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Endometrial Neoplasms; Female; H | 2012 |